Purification of transthyretin and transthyretin fragments from amyloid-rich human tissues.
Transthyretin is the major amyloid fibril protein in many forms of familial systemic amyloidosis where a missense mutation creates an amyloidogenic protein, and in senile systemic amyloidosis in which wild-type transthyretin aggregates into amyloid fibrils. The amyloid deposits may consist of full-length transthyretin but is very often, in senile systemic amyloidosis always, a mixture of full-length transthyretin and C-terminal transthyretin fragments. The amyloid fibril protein mixture can be purified by extraction of fibrils followed by sequential gel filtration after solubilization in a solution of guanidine hydrochloride. Since the C-terminal transthyretin fragments lack cysteine residues, a method to separate full-length transthyretin from fragments by covalent chromatography has been developed.
Westermark
Per
P
Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Sweden.
Westermark
Gunilla T
GT
D002845:Chromatography / Q000379:methods; D004591:Electrophoresis, Polyacrylamide Gel / Q000379:methods; D006801:Humans; D009206:Myocardium / Q000378:metabolism; D010446:Peptide Fragments / Q000302:isolation & purification* / Q000378:metabolism; D011228:Prealbumin / Q000302:isolation & purification* / Q000378:metabolism
D010446:Peptide Fragments; D011228:Prealbumin